Unlike alendronate and similar drugs, Prolia stops working as soon as you stop taking it, so people who are on it need to ...
New evidence shows that extended estrogen suppression treatment using an aromatase inhibitors for hormone receptor-positive postmenopausal breast cancer is safe; it does not increase the risk of ...
High blood pressure, or hypertension, affects more than one billion people worldwide and is a leading cause of heart disease ...
A new study from researchers at Baylor College of Medicine brings hope for a more personalized approach to treat estrogen receptor-positive (ER+) breast cancer, the most common type of this cancer.
Estrogen may help protect against hypertension in premenopause, a new study suggests, raising further questions about the role that hormone therapy may play in cardiovascular health later in life.
Hosted on MSN
Biomarker brings ER+ breast cancer patients one step closer to more personalized therapy
A new study by researchers at Baylor College of Medicine brings hope for a more personalized approach to treating estrogen receptor-positive (ER+) breast cancer, the most common type of this cancer.
A treatment known as ovarian suppression used along with an anti-estrogen drug normally given to older women appears to greatly reduce the risk of breast cancer recurrence in some younger women, new ...
An estrogen-like drug, raloxifene, has no demonstrated benefit on memory and thinking skills for women with dementia due to Alzheimer's disease, according to a study published in the November 4, 2015, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results